Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1)

Target
UBE2V2P1
Molecular classification
Other (Pseudogene)
01

Overview

Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1) is characterized as a pseudogene, meaning it is a genomic sequence related to the UBE2V gene family but is not believed to encode a functional enzyme or protein. Pseudogenes arise from gene duplication or retrotransposition events and often acquire mutations that render them non-functional. There is no evidence to suggest that UBE2V2P1 is expressed as a protein or plays a direct biological or pathological role. Accordingly, it is not a therapeutic target and has no known drug interactions, disease associations, or translational biomarker value. The functional gene family (UBE2V1/UBE2V2) encodes ubiquitin-conjugating E2 variant enzymes, which, in their canonical form, participate in the ubiquitination pathway (regulating protein degradation, cell signaling, and other processes). This pseudogene is sometimes annotated in error or discussed in relation to its functional paralogs, but it does not itself encode an active enzyme or therapeutic target. If a query is actually targeting a functional E2 family member (such as UBE2V1 or UBE2V2), information about those proteins should be sought separately, as they have known roles in protein ubiquitination and disease processes, whereas UBE2V2P1 itself does not. UBE2V2P1 is a pseudogene, not a functional gene, enzyme, or target. It does not encode an active protein and is not relevant for drug targeting, biomarker applications, or disease association based on current scientific knowledge.

Other names
UBE2V2P1ubiquitin conjugating enzyme E2 variant 2 pseudogene 1

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V2 pseudogene 1 (UBE2V2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call